Prosurvival and Chemoprotective Effects of Tumor-Associated Macrophages Reversed By Anti-CSF-1R Monoclonal Antibody in B-Cell Lymphomas

被引:0
|
作者
Gopisetty, Anupama [1 ]
Foglietta, Myriam [2 ]
Zhang, Min [3 ]
Wang, Zhiqiang [3 ]
Fowler, Nathan [3 ]
Davis, Richard E. [3 ]
Neelapu, Sattva S. [3 ]
机构
[1] MD Andeson Canc Ctr, Houston, TX USA
[2] Univ Turin, Citta Salute & Sci Torino, Turin, Italy
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] In Vitro and In Vivo Effects of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas
    Chu, Fuliang
    Foglietta, Myriam
    Qin, Hong
    Sharma, Rakesh
    Yi, Qing
    Rodionov, Galina
    Rotem-Yehudar, Rinat
    Neelapu, Sattva
    BLOOD, 2009, 114 (22) : 302 - 302
  • [32] Exploratory biomarker program in Phase I clinical development of RG7155, a novel humanized anti-CSF-1R Mab, targeting Tumor Associated Macrophages (TAMs).
    Cannarile, Michael A.
    Habben, Kai
    Heil, Florian
    Broeske, Ann-Marie
    Ruettinger, Dominik
    Culton, Lisa
    Feuerhake, Friedrich
    Ries, Carola H.
    CANCER RESEARCH, 2013, 73 (08)
  • [33] Targeting tumor-asoociated macrophages with a novel anti-CSF1R antibody in cancer patients
    Cannarile, Michael
    Hoves, Sabine
    Broeske, Ann-Marie
    Benz, Joerg
    Wartha, Katharina
    Runza, Valeria
    Rey-Giraud, Flora
    Pradel, Leon P.
    Feuerhake, Friedrich
    Klaman, Irina
    Jones, Tobin
    Jucknischke, Ute
    Scheiblich, Stefan
    Gorr, Ingo H.
    Walz, Antje
    Abiraj, Keelara
    Cassier, Philippe
    Sica, Antonio
    Gomez-Roca, Carlos
    Le Tourneau, Christophe
    Delord, Jean-Pierre
    Italiano, Antoine
    Levitsky, Hyam
    Blay, Jean-Yves
    Ruettinger, Dominik
    Ries, Carola H.
    CANCER RESEARCH, 2015, 75 (01)
  • [34] B-CELL ASSOCIATED MONOCLONAL-ANTIBODY L26 MAY OCCASIONALLY LABEL T-CELL LYMPHOMAS
    HAMILTONDUTOIT, SJ
    PALLESEN, G
    APMIS, 1989, 97 (11) : 1033 - 1036
  • [35] SELECTIVE INVIVO ANTITUMOR EFFECTS OF MONOCLONAL ANTI-I-A ANTIBODY ON B-CELL LYMPHOMA
    BRIDGES, SH
    KRUISBEEK, AM
    LONGO, DL
    JOURNAL OF IMMUNOLOGY, 1987, 139 (12): : 4242 - 4249
  • [36] GLIOBLASTOMA GENETIC DRIVERS DICTATE THE FUNCTION OF TUMOR-ASSOCIATED MACROPHAGES/MICROGLIA AND RESPONSES TO CSF1R INHIBITION
    Rao, Rohit
    Han, Rong
    Ogurek, Sean
    Wu, Lai Man
    Zhang, Liguo
    Hu, Jian
    Garrett, Matthew
    Phoenix, Tim
    Waggoner, Stephen N.
    Lu, Qing Richard
    NEURO-ONCOLOGY, 2021, 23 : 204 - 204
  • [37] Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition
    Rao, Rohit
    Han, Rong
    Ogurek, Sean
    Xue, Chengbin
    Wu, Lai Man
    Zhang, Liguo
    Zhang, Li
    Hu, Jian
    Phoenix, Timothy N.
    Waggoner, Stephen N.
    Lu, Q. Richard
    NEURO-ONCOLOGY, 2022, 24 (04) : 584 - 597
  • [38] Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
    Sato, Takahiko
    Sugiyama, Daisuke
    Koseki, Jun
    Kojima, Yasuhiro
    Hattori, Satomi
    Sone, Kazuki
    Nishinakamura, Hitomi
    Ishikawa, Tomohiro
    Ishikawa, Yuichi
    Kato, Takuma
    Kiyoi, Hitoshi
    Nishikawa, Hiroyoshi
    JCI INSIGHT, 2025, 10 (01)
  • [39] First-in-human study of AMG 820, a monoclonal anti-CSF-1R (c-fms) antibody, in patients (pts) with advanced solid tumors
    Papadopoulos, Kyriakos
    Gluck, Larry
    Martin, Lainie P.
    Olszanski, Anthony J.
    Ngarmchamnanrith, Gateree
    Rasmussen, Erik
    Amore, Benny
    Nagorsen, Dirk
    Hill, John S.
    Stephenson, Joe
    CANCER RESEARCH, 2016, 76
  • [40] IL-28B reprograms tumor-associated macrophages to promote anti-tumor effects in colon cancer
    Cheng, Dalei
    Wang, Haiyan
    Cheng, Hongyan
    Zhang, Hui
    Dong, Guanjun
    Yan, Fenglian
    Ning, Zhaochen
    Wang, Changying
    Wei, Li
    Zhang, Xin
    Zhang, Junfeng
    Xiong, Huabao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109